Why doctors choose a $2,000 drug over a $50 alternative

Source: Peter Whoriskey and Dan Keating - The Washington Post

The two drugs have been declared equivalently miraculous. Tested side by side in six major trials, both prevent blindness in a common old-age affliction. Biologically, they are cousins. They’re even made by the same company.

But one holds a clear price advantage.

Read Full Article: Why doctors choose a $2,000 drug over a $50 alternative

 
 

Quick Menu

Facebook FTwitter T

Consumer Help Desk

Advocacy